Results 191 to 200 of about 639,077 (240)

Valaciclovir therapy for secondary suppression of immune response to herpesviruses: An exploratory study. [PDF]

PLoS Pathog
McGee K, Dowell A, Lauder S, Begum J, Chagoury O, Croft W, Middleton L, Sun Y, Zuo J, McManus R, Moss P.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Human herpesvirus infections and circulating microvesicles expressing galectin-3 binding protein in patients with systemic lupus erythematosus

Clinical and Experimental Rheumatology, 2022
Circulating microvesicles (MVs) expressing the type 1 interferon-inducible protein galectin-3 binding protein (G3BP) are potentially major sources of autoantigens in systemic lupus erythematosus (SLE). In this study, we explore if plasma concentrations of G3BP-expressing MVs correlate with signs of various active human herpesvirus (HHV) infections in ...
Rasmussen, Niclas S., Draborg, Anette H., Houen, Gunnar, Nielsen, Christoffer T.   +3 more
openaire   +3 more sources

Epigallocatechin-3-gallate downregulates PDHA1 interfering the metabolic pathways in human herpesvirus 8 harboring primary effusion lymphoma cells

Toxicology in Vitro, 2020
Primary effusion lymphoma (PEL) is an aggressive neoplasm correlated with human herpesvirus 8 (HHV8). Metabolic reprogramming is a hallmark of cancers. The alterations in cellular metabolism are important to the survival of HHV8 latently infected cells.
Ling-Chun, Yeh, Huey-Wen, Shyu, Yi-Ru, Jin, Yee-Hsuan, Chiou, Kuan-Hua, Lin, Miao-Chen, Chou, Mei-Han, Huang, Yi-Fen, Wang   +7 more
openaire   +2 more sources

Review Part 3: Human herpesvirus‐6 in multiple non‐neurological diseases

Journal of Medical Virology, 2010
AbstractJ. Med. Virol. 82:1903–1910, 2010. © 2010 Wiley‐Liss, Inc.
Ablashi DV, Devin CL, Yoshikawa T, Lautenschlager I, LUPPI, Mario, Kühl U, Komaroff AL   +6 more
openaire   +3 more sources

Kaposi sarcoma herpesvirus/human herpesvirus‐8–negative effusion‐based lymphoma: Report of 3 cases and review of the literature

Cancer Cytopathology, 2013
BACKGROUNDPrimary effusion lymphoma (PEL) is a rare subtype of large B‐cell lymphoma that arises in body cavities without detectable tumor masses. PEL is universally associated with Kaposi sarcoma herpesvirus (KSHV)/human herpesvirus‐8 (HHV8). Despite overlapping features, KSHV/HHV8‐negative effusion‐based lymphoma is a distinct entity from PEL.
Jingnan, Xiao, Suzanne M, Selvaggi, Catherine P, Leith, Sean A, Fitzgerald, Jimmie, Stewart   +4 more
openaire   +2 more sources